Saniona Changes Date of Annual Report for 2021
April 27 2022 - 1:00AM
Saniona Changes Date of Annual Report for 2021
PRESS RELEASE
April
27,
2022
Saniona (OMX: SANION), a
clinical-stage biopharmaceutical
company focused on rare diseases, today
announced that the Board of Directors of
Saniona AB has resolved to change the date of the Annual Report for
2021 from April 29, 2022
to April 30,
2022.
The updated 2022
financial calendar is as follows:Annual Report
2021: April 30, 2022Interim Report Q1: May 25, 2022 at 8:00 CEST
Annual General Meeting: May 25, 2022 Interim Report Q2: August 25,
2022 at 8:00 CEST Interim Report Q3: November 17, 2022 at 8:00 CET
Year-End Report 2022: February 23, 2023 at 8:00 CET
For more information, please contact Thomas
Feldthus, incoming CEO, +45 22109957;
thomas.feldthus@saniona.com
This information was submitted for publication, through the
agency of the contact person set out above, at 8.00 CEST on 27
April 2022.
About Saniona Saniona is a clinical-stage
biopharmaceutical company with a mission to leverage its ion
channel targeting expertise to discover, develop and deliver
innovative rare disease treatments. The company’s most advanced
product candidate, Tesomet™, has been progressed into mid-stage
clinical trials for hypothalamic obesity and Prader-Willi syndrome,
serious rare disorders characterized by severe weight gain,
disturbances of metabolic functions and uncontrollable hunger.
These clinical trials are voluntarily paused due to funding
limitations and Saniona is actively exploring partnering
opportunities. Saniona has developed a proprietary ion channel drug
discovery engine anchored by IONBASE™, a database of more than
130,000 compounds, of which more than 20,000 are Saniona’s
proprietary ion channel modulators. Through its ion channel
expertise, Saniona is advancing two wholly-owned ion channel
modulators, SAN711 and SAN903. SAN711 is in a Phase 1 clinical
trial and is positioned for the treatment of neuropathic pain
conditions, and SAN903 is in preclinical development for rare
inflammatory, fibrotic and hematological disorders. Saniona is
based in the Copenhagen area, Denmark, and is listed on Nasdaq
Stockholm Small Cap (OMX: SANION). Read more
at http://www.saniona.com.
- Financial Calendar 04.27.22
Saniona Ab (LSE:0RQJ)
Historical Stock Chart
From Jan 2025 to Feb 2025
Saniona Ab (LSE:0RQJ)
Historical Stock Chart
From Feb 2024 to Feb 2025
